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Objective: To estimate the incidence, survival, and lifetime risk of stroke in the elderly population.
Methods: The authors conducted a study in 7721 participants from the population based Rotterdam
Study who were free from stroke at baseline (1990–1993) and were followed up for stroke until
1 January 1999. Age and sex specific incidence, case fatality rates, and lifetime risks of stroke were
calculated.
Results: Mean follow up was 6.0 years and 432 strokes occurred. The incidence rate of stroke per
1000 person years increased with age and ranged from 1.7 (95% CI 0.4 to 6.6) in men aged 55 to
59 years to 69.8 (95% CI 22.5 to 216.6) in men aged 95 years or over. Corresponding figures for
women were 1.2 (95% CI 0.3 to 4.7) and 33.1 (95% CI 17.8 to 61.6). Men and women had similar
absolute lifetime risks of stroke (21% for those aged 55 years). The survival after stroke did not differ
according to sex.
Conclusions: Stroke incidence increases with age, also in the very old. Although the incidence rate is
higher in men than in women over the entire age range, the lifetime risks were similar for both sexes.
In recent decades a decreasing trend in mortality of strokehas been observed.1–6 Nevertheless, stroke is among theleading causes of death in the Western countries and puts a
large burden on healthcare systems.7 8 Stroke incidence
increases with age, but information on the incidence and sur-
vival of stroke in the very old in the general population is lim-
ited. As populations are growing older this information is of
importance, particularly for healthcare planners.9 Also, data
on the risk of stroke during a person’s life are lacking and are
of interest on the individual level. We performed a large
prospective study on the incidence of stroke in a population
based cohort of elderly subjects aged 55 years or over, which
enabled us to calculate incidence rates, survival, case fatality,
and period and lifetime risks of stroke.
METHODS
Study population
This study was performed in the framework of the Rotterdam
Study, a population based, single centre cohort study on
chronic and disabling diseases in the elderly population. All
inhabitants of Ommoord, a suburb of Rotterdam, aged 55
years or more were invited. People living in homes for the eld-
erly were included.10 Participation rate of those invited for the
study was 78% and a total of 7983 subjects participated. The
Medical Ethics Committee of Erasmus University approved
the study. Written informed consent to retrieve information
from treating physicians was obtained from all participants.
Baseline measurements were obtained from 1990 to 1993 and
consisted of an interview at home and two visits to the
research centre for physical examination. During the inter-
view a previous stroke was assessed by asking “did you ever
suffer from a stroke, diagnosed by a physician?” Medical
records of subjects who answered “yes” were checked and a
previous stroke was considered to have occurred if medical
records confirmed it.11 This study comprises a cohort of 7721
subjects who were free from stroke at baseline. Follow up for
stroke was complete until 1 January 1999.
Assessment of stroke
Once subjects enter the Rotterdam Study they are continu-
ously monitored for major events through automated linkage
with files from the general practitioners. For this study infor-
mation on stroke and death was used. Stroke is defined as
rapidly developing clinical signs of focal or global disturbance
of cerebral function with no apparent cause other than a vas-
cular origin. When an event or death had been reported, addi-
tional information was obtained by interviewing the general
practitioner and by scrutinising information from hospital
discharge records in case of admittance or referral. Infor-
mation from reports on all possible strokes was reviewed by
two research physicians and a neurologist (PJK) who
classified the stroke as definite, probable, or possible stroke.12
The stroke was definite if the diagnosis was based on typical
clinical symptoms and neuroimaging excluded other diag-
noses. The stroke was considered probable in case typical
clinical symptoms were present but neuroimaging was not
performed. For fatal strokes, other causes of death, especially
cardiac should have been excluded. A stroke was classified as
possible if clinical symptoms were less typical and neuroimag-
ing was not performed, or if a cardiac cause of death could not
be excluded in case of a fatal stroke. All reported transient
ischaemic episodes also were reviewed in order to screen and
classify all strokes. Subarachnoid haemorrhages were ex-
cluded. Until the end of follow up 202 definite, 130 probable,
and 96 possible strokes occurred. We used definite and
probable strokes in the analyses (n=432). For subjects with a
stroke, follow up was complete until 1 January 1999. Case
fatality within 28 days was defined as death occurring within
28 days after onset of the stroke.
Subtypes of stroke
If the CT or MRI scan showed a cerebral haemorrhage or inf-
arction the type of stroke was coded accordingly. In case of no
abnormality on CT orMRI, the stroke was classified as cerebral
infarction. Strokes without neuroimaging could be classified
as possible haemorrhagic stroke or a cerebral infarction on the
basis of the following symptoms. A possible haemorrhagic
stroke was coded in case of sudden hemiplegia or other focal
signs with permanent unconsciousness or death within hours.
The stroke was classified as possible cerebral infarction if there
was limited impairment (isolated aphasia, isolated weakness
of one limb, isolated facial weakness, or isolated hemianopia),
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complete improvement within 72 hours or documented atrial
fibrillation at time of the stroke.
Data analysis
The age specific incidence rate was obtained for each five year
band by dividing the number of strokes by the total amount of
person years attributed to a specific age category. The follow
up ended either at occurrence of stroke, or at death, or at
1 January 1999, whichever came first. Participants who
suffered from a subarachnoidal haemorrhage were censored
on the date of the event. Incidence rates are given with 95%
confidence intervals (CI), assuming Poisson distribution. We
calculated incidence and 28 days case fatality rates for
subtypes of stroke in 10 year age ranges. For the calculation of
52 weeks case fatality rates we restricted ourselves to cases
that occurred before 31 December 1998. We used Cox propor-
tional hazards regression to investigate sex differences in risk
of stroke and survival after stroke. In these analyses we
adjusted for age at baseline and stroke, respectively. Survival
after stroke was calculated using the Kaplan-Meier method.
To calculate the absolute risk of stroke over time we took the
competing risk of dying into account. Firstly, we obtained the
stroke free survival at different ages from the cohort with the
Kaplan-Meier method. Age at baseline was used as entry time
and age at end of follow up, occurrence of stroke, or death as
failure time. Then the cumulative absolute risk of stroke over
a period was calculated as the integrated product of the age
specific stroke incidences and the stroke free survival.13 The
risk of stroke over time was calculated separately for men and
women at ages 55, 65, 75, and 85 years.
RESULTS
The mean follow up time was 6.0 years. We had 46 011 person
years of observation and 432 suffered from a first ever stroke.
Of these 39 were primary intracerebral haemorrhages (9.0%),
233 cerebral infarctions (53.9%), and 160 unspecified strokes
(37.0%). A CT or MRI scan was performed in 256 (59.3%)
cases and in two cases necropsy was performed. The haemor-
rhages and infarctions were confirmed by neuroimaging in
74.4% and respectively 94.4%. A total of 256 persons (59.3%)
were hospitalised. The incidence rate of stroke increased with
age and ranged from 1.7 (95% CI 0.4 to 6.6) inmen aged 55–59
years to 69.8 (95% CI 22.5 to 216.6) in men aged 95 or over
(table 1). Corresponding rates for women were 1.2 (95% CI 0.3
to 4.7) and 33.1 (95% CI 17.8 to 61.6), respectively. Incidence
rates were higher in men than in women over the entire age
range. Adjusted for age at baseline the relative risks of stroke
for men compared with women in partipants aged younger
and older than 75 years were respectively 1.64 (95% CI 1.26 to
2.15) and 1.36 (95% CI 1.02 to 1.83). Table 2 shows that the
incidence rate increased with age until the age of 85 for all
subtypes of stroke. After age 85, the proportion of unspecified
strokes became very high and estimates of the frequency of
subtypes of stroke less reliable. The proportion of hospitalised
strokes decreased with age in both sexes (fig 1).
Case fatality
The overall 28 days case fatality rate was 32.5% for all strokes,
12.4% for cerebral infarctions, and 33.3% for cerebral haemor-
rhages. Corresponding 52 week case fatality rates were 40.4,
23.6, and 62.9%. We observed no difference in survival after
stroke between men and women (fig 2). Case fatality rates of
stroke, cerebral infarction, and intracerebral haemorrhage
increased with age (table 3).
Lifetime risk of stroke
Figure 3 shows survival and stroke free survival for 55 and 75
years old participants as observed in the total study cohort.
The areas between the survival and stroke free survival curves
represent the average time subjects live after a stroke. The area
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comprised 3.45 (95% CI 2.93 to 3.97) years for men and 3.12
(95% CI 2.69 to 3.55) years for women aged 55 years.
Corresponding figures for persons aged 75 years were 2.16
(95% CI 1.59 to 2.73) and 2.10 (95% CI 1.63 to 2.57) years,
respectively. Table 4 shows the cumulative incidence of stroke
over time for men and women at different ages. The absolute
risk of getting a stroke is nearly similar for men and women in
all age categories, reflecting higher incidence rates, but shorter
life expectancy in men as compared with women.
DISCUSSION
We found that the incidence rate of stroke was higher in men
than in women over the entire age range. Nevertheless, as a
net result of a shorter life expectancy and a higher incidence
rate of stroke in men as compared with women, lifetime risks
of stroke in men and women were similar at different ages.
Case ascertainment
Studies on incidence of stroke are vulnerable to selection bias.
Although our participation rate was high (78%), it is conceiv-
able that non-participants had a higher risk profile for stroke.
Consequently, our incidence figures most probably are
conservative estimates of the true population incidence of
stroke. Complete and accurate case ascertainment is crucial
for the validity of the results of an incidence study. The
prospective study design, standard definitions, defined study
population, and multiple methods of case finding were in
accordance with core criteria proposed by Malmgren and
colleagues.14 Furthermore, the investigation and characteris-
tics of stroke in this study fulfil criteria for optimal case ascer-
tainment defined by researchers from the WHO MONICA
stroke study.15 The follow up was complete for all participants
and we used extensive and overlapping case finding methods
to reduce selection bias in follow up. The proportion of
non-hospitalised strokes in our study was 39%. This is in
accordance with the proportion (46%) found by the Oxford-
shire Stroke Project.16 Rotterdam with nearly 700 000 inhabit-
ants did not have a specific stroke admission strategy during
the study period. The low admission rate was mainly
explained by a shortage of hospital beds and by the fact that
stroke units and stroke services were not yet widespread
available and thrombolytic therapy not yet an established
treatment. A weakness of our study that results from the fact
that not all strokes were hospitalised is the comparatively low
proportion of CT or MRI confirmed strokes. We observed that
the proportion of unspecified strokes increased with age.
Restriction to only neuroimaging confirmed strokes would
have led to an underestimation of the incidence, especially in
the very old. As only 75% of the intracerebral haemorrhages
Table 2 Incidence rate of subtypes of stroke
Age
Cerebral infarction Intracerebral haemorrhage Unspecified stroke
Number of
cases
Incidence
rate* 95% CI†
Number of
cases
Incidence
rate* 95% CI†
Number of
cases
Incidence
rate* 95% CI†
55–64 17 1.5 1.0 to 2.5 2 0.2 0.0 to 0.7 3 0.3 0.1 to 0.8
65–74 72 4.0 3.2 to 5.1 10 0.6 0.3 to 1.0 26 1.4 1.0 to 2.1
75–84 111 9.0 7.5 to 10.9 22 1.8 1.2 to 2.7 52 4.2 3.2 to 5.6
85+ 33 6.9 4.9 to 9.8 5 1.1 0.4 to 2.5 79 16.6 13.3 to 20.7
All 233 5.1 4.5 to 5.8 39 0.8 0.6 to 1.2 160 3.5 3.0 to 4.1
*Rate per 1000 person years. †CI, confidence intervals.
Figure 1 Incidence rate per 1000 person years for stroke and
hospitalised stroke in relation to age in men and in women.
Table 3 Twenty eight day case fatality for stroke, subtypes of stroke, and hospitalised strokes
Age
Stroke Cerebral infarction Intracerebral haemorrhage Hospitalised stroke
Number/total % fatal Number/total % fatal Number/total % fatal Number/total % fatal
55–64 2/22 9.0 0/17 0.0 1/2 50.0 2/16 12.5
65–74 15/108 13.9 5/72 6.9 1/10 10.0 12/76 15.8
75–84 33/105 31.4 15/111 13.5 8/22 36.4 27/119 22.7
85+ 61/117 52.1 9/33 27.2 3/5 60.0 22/45 48.9
All 111/342 32.5 29/233 12.4 13/39 33.3 63/256 24.6
Figure 2 Cumulative survival after stroke according to sex,
adjusted for age at stroke.
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were confirmed by CT or MRI, the overall results on haemor-
rhages should be regarded carefully. Almost 95% of the
cerebral infarctions were CT confirmed. Therefore, we feel that
the overall figures on cerebral infarctions are reliable.
However, incidence figures of stroke subtypes in the very old
are less reliable.
Stroke incidence studies
One hospital based study in the Netherlands (1978–1980)
reported comparable, though slightly higher incidence rates of
stroke than our study, but did not analyse the very old.17 Pos-
sibly the incidence has declined during the time interval
between both studies. The incidence rates found in our study
are in accordance with the results from other studies in
Europe, although some studies reported lower incidence rates
in subjects >85 years.16 18–24 Studies in Eastern Europe reported
higher incidence rates in subjects younger than 85 years, and
lower rates in subjects older than 85.25–28 Incidence rates in
Eastern European countries are known to be higher than in
Western Europe. The lower rates in the very old in other stud-
ies might be explained by under-report of stroke in the elderly
population, as we have shown that the proportion of hospital-
ised strokes declines with age. Incidence rates of stroke in
subjects with a European background in Auckland, New Zea-
land (1992) were higher than in the Rotterdam Study.29 How-
ever, the North East Melbourne Stroke Incidence Study
(1996–1997) reported similar rates.30 In our study the survival
after stroke was equal in men and women.Most other studies
did not find sex differences either.29 31–34 We observed an
increasing case fatality with age, and a higher case fatality of
cerebral haemorrhages as compared with cerebral infarctions.
These results are in accordance with results from other
studies.21 29 33 35 36
Lifetime risk of stroke
Our calculations of lifetime risks of stroke were based on the
assumption that characteristics of the cohort remain constant
over time. They showed that although the incidence rate of
stroke in men was higher than in women, the lifetime risk to
get a stroke was similar when we took the competing risk of
dying into account. The higher incidence rate of stroke is
counterbalanced by shorter survival in men as compared with
women. As a consequence, women on average are older when
they get a stroke. In conclusion, stroke incidence increases
with age, also in the very old. Although incidence rates in men
were higher than in women over the entire age range, lifetime
risks were similar.
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